Acetaminophen Combo Products, Hepatotoxicity Link Absent – Pfizer
This article was originally published in The Tan Sheet
Executive Summary
A review of Pfizer Consumer Healthcare's in-house database of acetaminophen-related adverse events indicates no relationship between hepatotoxicity and the analgesic ingredient, the company says
You may also be interested in...
Most Acetaminophen Pediatric AERs Due To Medication Errors, FDA Asserts
Exceeding the recommended daily dose of acetaminophen resulted in hepatotoxic adverse events more often than use at or below recommended amounts, FDA says in 1briefing documents for the Nonprescription Drugs Advisory Committee meeting on analgesic safety Sept. 19-20
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands